Trial and cure-program status families can track.
Built from ClinicalTrials.gov status on programs we watch. Type1Cure never implies you are eligible — talk with your care team before any trial decision.
Programs with recruiting activity
From the live cure pipeline (8 programs tracked). Always verify on the registry page.
Recent trial feed items
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
RECRUITING, PHASE3. Interventions: Stem Cell Educator therapy. Locations: Paramus, New Jersey, United States | Paramus, New Jersey, United States. Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals worldwide have T1D, and incidence increases annually. Several recent clinical trials point to the need for an approach that produces comprehensive immune modulation at both...
VV-14300 for the Treatment of Type 1 Diabetes
RECRUITING, PHASE1, PHASE2. Interventions: VV-14300. Locations: Toronto, Canada | Christchurch, New Zealand. This study is testing VV-14300 in adults with long-standing type 1 diabetes (T1D) whose blood sugar is not well controlled despite using an automated insulin delivery (AID) system. VV-14300 is an investigational gene therapy that is injected into muscle and is designed to help remove excess sugar from the blood.
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
RECRUITING, PHASE2. Interventions: Cyclosporin, ILT101, Placebo. Locations: Paris, France. Type 1 diabetes (T1D) is caused by the destruction of insulin-producing cells by effector T cells (Teffs), due to a deficiency of regulatory T cells (Tregs). Ciclosporin effectively blocks the Teffs and controls diabetes, but cannot be considered as a long-term treatment. Low-dose interleukin-2 (ld IL-2) activates and expands Tregs in humans. Hence, Ld IL-2 in patie...
EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
RECRUITING, NA. Interventions: EmoTIChealth. Locations: Valencia, Valencia, Spain. The intervention program targets adolescents between 12 and 16 years of age. The intervention program is designed for adolescents during a critical developmental stage marked by significant life transitions, where building strong personal resources and receiving psychological support is essential to foster socioemotional skills and overall well-being. The serious game aims...
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
RECRUITING. Locations: Miami, Florida, United States. This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.
Islet Transplantation in Patients With "Brittle" Type I Diabetes
RECRUITING, NA. Interventions: Allogenic islet cells (human, U. Chicago), Intraportal infusion of islet cells. Locations: Chicago, Illinois, United States. The purpose of this study is to learn about the safety of islet transplantation for Type 1 diabetes mellitus, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. These cells will be obtai...
Optimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With Type 1 Diabetes: a Feasibility Study (D-stress Study)
RECRUITING, NA. Interventions: D-stress study: The detection, prevention and management of diabetes distress for adults living with type 1 diabetes.. Locations: Bath, United Kingdom | Leicester, United Kingdom | London, United Kingdom. Up to one in two adults with type 1 diabetes find living with and managing diabetes to be emotionally challenging. This 'emotional side' of diabetes - feeling worried, frustrated, overwhelmed, sad, burnt-out - is called dia...
Study on the Improvement of Metabolic Indicators in Type 1 Diabetes Patients
RECRUITING, NA. Interventions: structured education and regular follow-up. Locations: Beijing, China. In this study, type 1 diabetes patients from the outpatient department of Peking University First Hospital were selected as the research objects. The investigators plan to recruit 150 participants. Using the course and teaching plan of \"Take Control of My Life - Structured Education for Type 1 diabetes\" issued by the China Type 1 diabetes Allian...
Also on the tracker
- VX-264 (encapsulated islet cells)Early clinical trial
- Hypoimmune islet cells (UP421 / SC451)First-in-human / early research
- Cell Pouch islet transplantClinical trial
- Tegoprubart (immune protection)Clinical trial
- Teplizumab (Tzield)FDA approved (delays onset)
- KRIYA-839 gene therapyPreclinical
- Gene-edited cell replacementEarly research
These are research programs pursuing a functional cure or disease modification for type 1 diabetes. None is a confirmed, broadly available cure. Trial status is informational, not medical advice, and not a recruiting offer. Verify eligibility and details with the official trial record and a clinician.